New Drugs Being Explored in Kidney Cancer
Recent News & Updates
Coinciding with the observation of Pancreatic Cancer Awareness Month in November, CURE sat down for an interview with Dr. Rosario Ligresti to discuss a range of topics including the rising incidence of pancreatic cancer among relatively younger adults, common risk factors for the disease and advice for newly diagnosed patients.
In 2025, a new front opened in the war over healthcare costs, with Republicans joining Democrats in focusing on Pharmacy Benefit Managers (PBMs) as one of the drivers of high costs for prescription drugs. PBMs are the firms that are hired by employers and insurers to negotiate prices with drug manufacturers.
Millions of Americans carry hidden genetic mutations that increase their risk of cancer, regardless of their family’s cancer history, according to a new study.
The Federal Drug Administration said drugmakers have recalled more than 580,000 bottles of a blood pressure medication over concerns that it may include a cancer-causing chemical.
